EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 3.0

Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?

Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop Eom

Cancer Research and Treatment · 15.10.2023 · 55 (4) · 1190-1197

DOI: 10.4143/crt.2023.320 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Research and Treatment, erschienen am 15.10.2023. Verfasst von Saerom Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Pusan National University Hospital, National Research Foundation of Korea, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Epidermal growth factor receptor (EGFR) T790M mutations have been detected in the second or third rebiopsy, even if the T790M mutation was not identified in the first rebiopsy. This meta-analysis investigated the EGFR T790M mutation detection rates and its additional advantages with repeated rebiopsies.Materials and Methods We searched through the PubMed and EMBASE databases up to June 2022. Studies reporting rebiopsy to identify the EGFR T790M mutation in case of disease progression among patients with advanced non-small cell lung cancer and multiple rebiopsies were included. The quality of the included studies was checked using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool.

Results

Eight studies meeting the eligibility criteria, reporting 1,031 EGFR mutation–positive patients were selected. The pooled EGFR T790M mutation detection rate of the first and repeated rebiopsies were 0.442 (95% confidence interval [CI], 0.411 to 0.473; I2=84%; p < 0.01) and 0.465 (95% CI, 0.400 to 0.530; I2=69%; p < 0.01), respectively. Overall, the pooled detection rate of EGFR T790M mutation was 0.545 (95% CI, 0.513 to 0.576), which increased by 10.3% with repeated rebiopsies.

Conclusion

This meta-analysis identified that repeated rebiopsy increases the detection rate of EGFR T790M mutation by 10.3%, even if EGFR T790M mutation is not detected in the first rebiopsy. Our results indicate that the spatiotemporal T790M heterogeneity can be overcome with repeated rebiopsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansErbB ReceptorsMutationDrug Resistance, NeoplasmProtein Kinase InhibitorsBiopsyRetrospective Studies

Stichwörter der Autor:innen

BiopsyErbB receptorsLung neoplasmsMutation

Substanzen

ErbB ReceptorsAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
  • Department of Biostatistics, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.

Förderung

  • Pusan National University Hospital
  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Kim, S., Kim, S. H., Kim, J., Kim, M. H., Lee, M. K., & Eom, J. S. (2023). Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?. Cancer Research and Treatment, 55(4), 1190-1197. https://doi.org/10.4143/crt.2023.320

Vancouver

Kim S, Kim SH, Kim J, Kim MH, Lee MK, Eom JS. Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?. Cancer Research and Treatment. 2023;55(4):1190-1197. doi:10.4143/crt.2023.320

BibTeX
@article{Kim2023,
  author = {Kim, Saerom and Kim, Soo Han and Kim, Jinmi and Kim, Mi-Hyun and Lee, Min Ki and Eom, Jung Seop},
  title = {Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?},
  journal = {Cancer Research and Treatment},
  year = {2023},
  volume = {55},
  number = {4},
  pages = {1190--1197},
  doi = {10.4143/crt.2023.320}
}
Kostenlos starten →